Degranulation of Human Platelets by the Thrombin Receptor Peptide SFLLRN: Comparison with Degranulation by Thrombin

Summary

A new, simplified method of degranulating human platelets using the thrombin receptor peptide SFLLRN (20 |iM) is described; released fibrinogen cannot be converted to fibrin, and the platelets are not exposed to a proteolytic enzyme, as they are when thrombin is used for degranulation. The peptide-degranulated platelets regain their disc shape and are recovered as single platelets which have released approximately 90% of the contents of their dense granules. Their procoagulant activity is greater than that of control platelets, but somewhat less than that of thrombin-degranulated platelets. Without added fibrinogen, the peptide-degranulated platelets aggregate slightly in response to 50 μM SFLLRN, and to collagen, arachidonic acid, the thromboxane A₂ mimetic U46619, platelet activating factor, ADP, and the divalent cation ionophore A23187; added fibrinogen enhances aggregation caused by these agonists. Extensive aggregation of peptide-degranulated platelets is caused by thrombin in the absence of added fibrinogen; it may be that the alternative thrombin receptor that is not activated by SFLLRN is responsible for the strong response to thrombin. Aggregation responses to most of the agonists are greater than those observed previously (10) with thrombin-degranulated platelets. By this method, platelets are obtained that have been degranulated in a way that is similar to in vivo degranulation. They are useful for studies of platelet responses without the complicating effects of released granule contents, and for investigation of the characteristics and functions of platelets that have come in contract with release-inducing agents in vivo.

• References

• 1 Vu T-KH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-1068
• 2 Vu T-KH, Wheaton VI, Hung DT, Charo I, Coughlin SR. Domains specifying thrombin-receptor interaction. Nature 1991; 353: 674-677
• 3 Vassalo Jr RR, Kieber-Emmons T, Cichowski K, Brass LF. Structure function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J Biol Chem 1992; 267: 6081-6085
• 4 Rasmussen UB, Vouret-Craviari V, Jallat S, Schlesinger Y, Pages G, Pavirani A, Lecocq J-P, Pouyssegur J. Van Obberghen-Schilling E. cDNA cloning and expression of a hamster α-thrombin receptor coupled to Ca²⁺ mobilization. FEBS Lett 1991; 288: 123-128
• 5 Hui KY, Jakubowski JA, Wyss VL, Angleton EL. Minimal sequence requirement of thrombin receptor agonist peptide. Biochem Biophys Res Commun 1992; 184: 790-796
• 6 Vouret-Craviari V, Van Obberghen-Schilling E, Rasmussen UB, Pavirani A, Lecocq J-P, Pouyssegur J. Synthetic α-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis. Mol Biol Cell 1992; 3: 095-102
• 7 Kinlough-Rathbone RL, Rand ML, Packham MA. Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets. Blood 1993; 82: 103-106
• 8 Harfenist EJ, Guccione MA, Packham MA, Mustard JF. The use of the synthetic peptide, Gly-Pro-Arg-Pro, in the preparation of throm bin-degranulated rabbit platelets. Blood 1982; 59: 952-955
• 9 Kinlough-Rathbone RL, Perry DW, Packham MA, Mustard JF. Deaggregation of human platelets aggregated by thrombin. Thromb Haemostas 1985; 53: 42-44
• 10 Kinlough-Rathbone RL, Packham MA, Guccione MA, Richardson M, Harfenist EJ, Mustard JF. Characteristics of thrombin-degranu lated human platelets: development of a method that does not use proteolytic enzymes for deaggregation. Thromb Haemostas 1991; 65: 403-410
• 11 Kinlough-Rathbone RL, Packham MA, Perry DW, Mustard JF, Cattaneo M. Lack of stability of aggregates after thrombin-induced reaggregation of thrombin-degranulated platelets. Thromb Haemostas 1992; 67: 453-457
• 12 Coughlin SR, Vu T-KH, Hung DT, Wheaton VI. Characterization of a functional thrombin receptor. Issues and opportunities. J Clin Invest 1992; 89: 351-355
• 13 McGowan EB, Detwiler TC. Modified platelet responses to thrombin. Evidence for two types of receptors or coupling mechanisms. J Biol Chem 1986; 261: 739-746
• 14 Holmsen H, Dangelmaier CA, Holmsen H-K. Thrombin-induced platelet responses differ in requirement for receptor occupancy. Evidence for tight coupling of occupancy and compartmentalized phosphatidic acid formation. J Biol Chem 1981; 256: 9393-9396
• 15 Seiler SM, Goldenberg HJ, Michel IM, Hunt JT, Zavoico GB. Multiple pathways of thrombin-induced platelet activation differen tiated by desensitization and a thrombin exosite inhibitor. Biochem Biophys Res Commun 1991; 181: 636-643
• 16 Bahou W, Goligorsky M, Potter C, Scudder L, Kutok J, Coller B. Thrombin receptor N-terminal sequence contains sites crucial for peptide ligand-mediated activation. Blood 1992; 80: 165 a
• 17 Greco NJ, Jones GD, Tandon NN, Jamieson GA. High and moderate affinity receptors are required for optimal platelet activation by α-thrombin. Blood 1992; 80: 264a
• 18 Gralnick HR, Williams S, McKeown L, Hansmann K, Vail M, Krutzsch H, Brass LF. The presence and function of the seven transmembrane thrombin receptor on Bemard-Soulier platelets. Blood 1992; 80: 265a
• 19 Brass LF, Vassallo Jr RR, Belmonte E, Ahuja M, Cichowski K, Hoxie JA. Structure and function of the human platelet thrombin receptor. J Biol Chem 1992; 267: 13795-13798
• 20 Cazenave J-P, Packham MA, Mustard JF. Adherence of platelets to a collagen-coated surface: development of a quantitative method. J Lab Clin Med 1973; 82: 978-990
• 21 Molnar J, Lorand L. Studies on apyrases. Arch Biochem Biophys 1961; 93: 353-363
• 22 Kinlough-Rathbone RL, Packham MA, Mustard JF. Platelet aggregation. In: Methods in Hematology. Measurements of Platelet Function. Harker LA, Zimmerman TS. (eds). Churchill Livingstone: Edinburgh; 1983. pp 64-91
• 23 Mustard JF, Kinlough-Rathbone RL, Packham MA. Isolation of human platelets from plasma by centrifugation and washing. In: Methods in Enzymology Platelets: Receptors, Adhesion, Secretion. Part A Hawiger J. (ed). 1989; 169: 03-11
• 24 Zucker MB. Platelet aggregation measured by the photometric method. In: Methods in Enzymology Platelets: Receptors, Adhesion, Secretion. Part A Hawiger J. (ed). 1989; 169: 117-133
• 25 Bevers EM, Comfurius P, Van Rijn JLML, Hemker HC, Zwaal RFA. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122: 429-436
• 26 Seiler SM, Michel IM, Fenton II JW. Involvement of the “tetheredligand” receptor in thrombin inhibition of platelet adenylate cyclase. Biochem Biophys Res Commun 1992; 182: 1296-1302
• 27 Wencel-Drake J. Plasma membrane GPIIb/IIIa. Evidence for a cycling receptor pool. Am J Pathol 1990; 136: 61-70
• 28 Legrand C, Dubernard V, Nurden AT. Studies on the mechanism of expression of secreted fibrinogen on the surface of activated human platelets. Blood 1989; 73: 1226-1234
• 29 Packham MA, Kinlough-Rathbone RL, Mustard JF. Thrombox ane A₂ causes feedback amplification involving extensive thrombox ane A₂ formation upon close contact of human platelets in media with a low concentration of ionized calcium. Blood 1987; 70: 827-831
• 30 Zwaal RFA, Bevers EM, Comfurius P, Rosing J, Tilly RHJ, Verhallen PFJ. Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance. Mol Cell Biochem 1989; 91: 23-31
• 31 Bauman JE, Reimers HJ, Joist JH. Deaggregation of in vitro-degranulated human platelets: irreversibility of aggregation may be agonist-specific rather than related to secretion per se. Thromb Haemostas 1987; 58: 899-904
• 32 White JR, Escolar G, Rao GHR, Vercellotti GM, White JG. Plateletplasts: a new model of platelet degranulation. Blood 1992; 80: 370a